Our program was initially started in 2016 with the mission of reimagining how men can be more easily treated for one of the most common disease states in the world affecting men, Benign Prostatic Hyperplasia (BPH). Prodeon Medical, Inc. has developed and is investigating a minimally invasive and patient-friendly approach to treating Lower Urinary Tract Symptoms (LUTS) due to BPH 
The procedure, known as the PURE™ (Prostatic Urethral REshaping) procedure uses the investigational the Urocross™ Expander System and Retrieval Sheath to relieve symptoms associated with BPH.

Caution: The Urocross Expander System and Retrieval Sheath are for investigational use only under the Expander-2 Clinical Trial (NCT: 05400980) and are not for sale in the U.S. or outside the U.S.

Biotechnology

Health Care

Medical Devices

Prodeon Medical, Inc.

Paul M. Edwards

Dan Condon

Jayachandran Ravichandran

Craig Purdy

Kimberly Marquez

Ted McKittrick Acrp-Cp

The Leadership Team at Prodeon Medical, Inc. is responsible for guiding the strategic direction of the company, ensuring that innovative solutions like the PURE™ procedure are developed in alignment with regulatory standards and clinical needs. They oversee operations, drive quality assurance, and lead clinical initiatives, fostering collaboration among engineering, clinical, and regulatory functions to bring safe and effective treatments for men suffering from BPH to market.

Leadership Team

Clinical Research Team

Leadership Team

About

Team members

Other teams at Prodeon Medical, Inc.

Clinical Research Team